Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Proteomics|April 6, 2019
iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer TumorsPascal Jézéquel, Catherine Guette, Hamza Lasla, et al.
BMC Medical Genomics|November 25, 2015
Gene-expression signature functional annotation of breast cancer tumours in function of agePascal Jézéquel, Zein Sharif, Hamza Lasla, et al.
Bulletin Du Cancer|September 25, 2021
[Interest of the bc-GenExMiner web tool in oncology]Pascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz, et al.
Scientific Reports|April 2, 2026
Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBCRamón García-Areas, Elodie Girard, Hamza Lasla, et al.
Database : the Journal of Biological Databases and Curation|February 18, 2021
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analysesPascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz, et al.
Cancer Research Communications|March 16, 2023
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer HormonotherapyAgnes Basseville, Chiara Cordier, Fadoua Ben Azzouz, et al.
Breast Cancer (Tokyo, Japan)|May 22, 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtypePascal Jézéquel, Hamza Lasla, Wilfried Gouraud, et al.
Breast Cancer Research : BCR|April 19, 2015
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune responsePascal Jézéquel, Delphine Loussouarn, Catherine Guérin-Charbonnel, et al.
Molecular Oncology|June 15, 2025
A DIA-MS-based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patientsAnne Clavreul, François Guillonneau, Odile Blanchet, et al.
Pageof 2